BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu X, Li J, Sun X, Guo Y, Chu D, Wei L, Li X, Yang G, Liu X, Yao L, Zhang J, Shen L. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression. Oncotarget 2015;6:26161-76. [PMID: 26317652 DOI: 10.18632/oncotarget.4544] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Shen L, Qu X, Li H, Xu C, Wei M, Wang Q, Ru Y, Liu B, Xu Y, Li K, Hu J, Wang L, Ma Y, Li M, Lai X, Gao L, Wu K, Yao L, Zheng J, Zhang J. NDRG2 facilitates colorectal cancer differentiation through the regulation of Skp2-p21/p27 axis. Oncogene 2018;37:1759-74. [PMID: 29343851 DOI: 10.1038/s41388-017-0118-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
2 Hu M, Liu L, Yao W. Activation of p53 by costunolide blocks glutaminolysis and inhibits proliferation in human colorectal cancer cells. Gene 2018;678:261-9. [PMID: 30103008 DOI: 10.1016/j.gene.2018.08.048] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
3 Li C, Wang P, Du J, Chen J, Liu W, Ye K. LncRNA RAD51-AS1/miR-29b/c-3p/NDRG2 crosstalk repressed proliferation, invasion and glycolysis of colorectal cancer. IUBMB Life 2021;73:286-98. [PMID: 33314669 DOI: 10.1002/iub.2427] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Huang LL, Tang M, Du QQ, Liu CX, Yan C, Yang JL, Li Y. The effects and mechanisms of a biosynthetic ginsenoside 3β,12β-Di-O-Glc-PPD on non-small cell lung cancer. Onco Targets Ther 2019;12:7375-85. [PMID: 31571900 DOI: 10.2147/OTT.S217039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hu W, Fan C, Jiang P, Ma Z, Yan X, Di S, Jiang S, Li T, Cheng Y, Yang Y. Emerging role of N-myc downstream-regulated gene 2 (NDRG2) in cancer. Oncotarget. 2016;7:209-223. [PMID: 26506239 DOI: 10.18632/oncotarget.6228] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 6.7] [Reference Citation Analysis]
6 Wozniak JM, Silva TA, Thomas D, Siqueira-Neto JL, McKerrow JH, Gonzalez DJ, Calvet CM. Molecular dissection of Chagas induced cardiomyopathy reveals central disease associated and druggable signaling pathways. PLoS Negl Trop Dis 2020;14:e0007980. [PMID: 32433643 DOI: 10.1371/journal.pntd.0007980] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Han L, Zan Y, Huang C, Zhang S. NELFE promoted pancreatic cancer metastasis and the epithelial‑to‑mesenchymal transition by decreasing the stabilization of NDRG2 mRNA. Int J Oncol 2019;55:1313-23. [PMID: 31638184 DOI: 10.3892/ijo.2019.4890] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
8 Yu L, Chen X, Sun X, Wang L, Chen S. The Glycolytic Switch in Tumors: How Many Players Are Involved? J Cancer 2017;8:3430-40. [PMID: 29151926 DOI: 10.7150/jca.21125] [Cited by in Crossref: 78] [Cited by in F6Publishing: 69] [Article Influence: 15.6] [Reference Citation Analysis]
9 Yu L, Chen X, Wang L, Chen S. The sweet trap in tumors: aerobic glycolysis and potential targets for therapy. Oncotarget 2016;7:38908-26. [PMID: 26918353 DOI: 10.18632/oncotarget.7676] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 13.8] [Reference Citation Analysis]
10 Sen U, Shenoy P S, Bose B. Opposing effects of low versus high concentrations of water soluble vitamins/dietary ingredients Vitamin C and niacin on colon cancer stem cells (CSCs): CSC and vitamins-proliferation versus killing. Cell Biol Int 2017;41:1127-45. [DOI: 10.1002/cbin.10830] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
11 Zhu Z, Tang G, Yan J. MicroRNA-122 regulates docetaxel resistance of prostate cancer cells by regulating PKM2. Exp Ther Med 2020;20:247. [PMID: 33178345 DOI: 10.3892/etm.2020.9377] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Li X, Hou G, Zhu Z, Yan F, Wang F, Wei D, Zheng Y, Yuan J, Zheng W, Zhang G, Meng P, Guo Y, Li X, Yao L, Shen L, Yuan J. The tumor suppressor NDRG2 cooperates with an mTORC1 inhibitor to suppress the Warburg effect in renal cell carcinoma. Invest New Drugs 2020;38:956-66. [DOI: 10.1007/s10637-019-00839-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Hon KW, Zainal Abidin SA, Othman I, Naidu R. The Crosstalk Between Signaling Pathways and Cancer Metabolism in Colorectal Cancer. Front Pharmacol 2021;12:768861. [PMID: 34887764 DOI: 10.3389/fphar.2021.768861] [Reference Citation Analysis]
14 Wu C, Zheng M, Gao S, Luan S, Cheng L, Wang L, Li J, Chen L, Li H. A natural inhibitor of kidney-type glutaminase: a withanolide from Physalis pubescens with potent anti-tumor activity. Oncotarget 2017;8:113516-30. [PMID: 29371926 DOI: 10.18632/oncotarget.23058] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
15 Wei Y, Yu S, Zhang Y, Zhang Y, Zhao H, Xiao Z, Yao L, Chen S, Zhang J. NDRG2 promotes adriamycin sensitivity through a Bad/p53 complex at the mitochondria in breast cancer. Oncotarget 2017;8:29038-47. [PMID: 28423695 DOI: 10.18632/oncotarget.16035] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
16 Hutton JE, Wang X, Zimmerman LJ, Slebos RJ, Trenary IA, Young JD, Li M, Liebler DC. Oncogenic KRAS and BRAF Drive Metabolic Reprogramming in Colorectal Cancer. Mol Cell Proteomics 2016;15:2924-38. [PMID: 27340238 DOI: 10.1074/mcp.M116.058925] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 7.8] [Reference Citation Analysis]
17 Chen W, Peng J, Ou Q, Wen Y, Jiang W, Deng Y, Zhao Y, Wan D, Pan Z, Fang Y. Expression of NDRG2 in Human Colorectal Cancer and its Association with Prognosis. J Cancer 2019;10:3373-80. [PMID: 31293640 DOI: 10.7150/jca.31382] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
18 Zhao J, Zhao Q, Mao S. N-myc downstream regulated gene 2 ameliorates myocardial remodeling and cardiac function in heart failure rats. Hum Exp Toxicol 2021;40:1296-307. [PMID: 33583230 DOI: 10.1177/0960327121993208] [Reference Citation Analysis]
19 Yu W, Yang X, Zhang Q, Sun L, Yuan S, Xin Y. Targeting GLS1 to cancer therapy through glutamine metabolism. Clin Transl Oncol 2021. [PMID: 34023970 DOI: 10.1007/s12094-021-02645-2] [Reference Citation Analysis]
20 Kim A. Mitochondria in Cancer Energy Metabolism: Culprits or Bystanders? Toxicol Res 2015;31:323-30. [PMID: 26877834 DOI: 10.5487/TR.2015.31.4.323] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
21 Guo Y, Li X, Sun X, Wang J, Yang X, Zhou X, Liu X, Liu W, Yuan J, Yao L, Li X, Shen L. Combined Aberrant Expression of NDRG2 and LDHA Predicts Hepatocellular Carcinoma Prognosis and Mediates the Anti-tumor Effect of Gemcitabine. Int J Biol Sci 2019;15:1771-86. [PMID: 31523182 DOI: 10.7150/ijbs.35094] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
22 Bazile J, Picard B, Chambon C, Valais A, Bonnet M. Pathways and biomarkers of marbling and carcass fat deposition in bovine revealed by a combination of gel-based and gel-free proteomic analyses. Meat Science 2019;156:146-55. [DOI: 10.1016/j.meatsci.2019.05.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
23 Vaes N, Schonkeren SL, Brosens E, Koch A, Mccann CJ, Thapar N, Hofstra RM, van Engeland M, Melotte V. A combined literature and in silico analysis enlightens the role of the NDRG family in the gut. Biochimica et Biophysica Acta (BBA) - General Subjects 2018;1862:2140-51. [DOI: 10.1016/j.bbagen.2018.07.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
24 Álvaro E, Cano JM, García JL, Brandáriz L, Olmedillas-López S, Arriba M, Rueda D, Rodríguez Y, Cañete Á, Arribas J, Inglada-Pérez L, Pérez J, Gómez C, García-Arranz M, García-Olmo D, Goel A, Urioste M, González-Sarmiento R, Perea J. Clinical and Molecular Comparative Study of Colorectal Cancer Based on Age-of-onset and Tumor Location: Two Main Criteria for Subclassifying Colorectal Cancer. Int J Mol Sci 2019;20:E968. [PMID: 30813366 DOI: 10.3390/ijms20040968] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
25 Yu Y, Guo M, Wei Y, Yu S, Li H, Wang Y, Xu X, Cui Y, Tian J, Liang L, Peng K, Liu T. FoxO3a confers cetuximab resistance in RAS wild-type metastatic colorectal cancer through c-Myc. Oncotarget 2016;7:80888-900. [PMID: 27825133 DOI: 10.18632/oncotarget.13105] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
26 Sharma SH, Thulasingam S, Chellappan DR, Chinnaswamy P, Nagarajan S. Morin and Esculetin supplementation modulates c-myc induced energy metabolism and attenuates neoplastic changes in rats challenged with the procarcinogen 1,2 - dimethylhydrazine. European Journal of Pharmacology 2017;796:20-31. [DOI: 10.1016/j.ejphar.2016.12.019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
27 Tao L, Zhu Y, Wang R, Han J, Ma Y, Guo H, Tang W, Zhuo L, Fan Z, Yin A, Hou W, Li Y. N-myc downstream-regulated gene 2 deficiency aggravates memory impairment in Alzheimer's disease. Behav Brain Res 2020;379:112384. [PMID: 31778735 DOI: 10.1016/j.bbr.2019.112384] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
28 Yang K, Wu C, Zheng M, Tang R, Li X, Chen L, Li H. Physapubescin I from husk tomato suppresses SW1990 cancer cell growth by targeting kidney-type glutaminase. Bioorganic Chemistry 2019;92:103186. [DOI: 10.1016/j.bioorg.2019.103186] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
29 Gu A, Xu J, Ye J, Zhang C. Low NDRG2 expression predicts poor prognosis in solid tumors: A meta-analysis of cohort study. Medicine (Baltimore) 2020;99:e22678. [PMID: 33031336 DOI: 10.1097/MD.0000000000022678] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Sun H, Huang Z, Sheng W, Xu MD. Emerging roles of long non-coding RNAs in tumor metabolism. J Hematol Oncol 2018;11:106. [PMID: 30134946 DOI: 10.1186/s13045-018-0648-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 8.8] [Reference Citation Analysis]
31 Jianyong Z, Jianjun X, Yongzhong O, Junwen L, Haiyan L, Dongliang Y, Jinhua P, Junwen X, Huanwen C, Yiping W. Rapid discrimination of human oesophageal squamous cell carcinoma by mass spectrometry based on differences in amino acid metabolism. Sci Rep 2017;7:3738. [PMID: 28623324 DOI: 10.1038/s41598-017-03375-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
32 Zhang X, Dong Z, Cui H. Interplay between Epigenetics and Cellular Metabolism in Colorectal Cancer. Biomolecules 2021;11:1406. [PMID: 34680038 DOI: 10.3390/biom11101406] [Reference Citation Analysis]
33 Zhai Z, Mu T, Zhao L, Li Y, Zhu D, Pan Y. MiR-181a-5p facilitates proliferation, invasion, and glycolysis of breast cancer through NDRG2-mediated activation of PTEN/AKT pathway. Bioengineered 2022;13:83-95. [DOI: 10.1080/21655979.2021.2006974] [Reference Citation Analysis]
34 Shi W, Xu X, Yan F, Wang B, Zhao H, Chan A, Ren Z, Ma Y, Wang F, Yuan J. N-Myc downstream-regulated gene 2 restrains glycolysis and glutaminolysis in clear cell renal cell carcinoma. Oncol Lett 2017;14:6881-7. [PMID: 29163707 DOI: 10.3892/ol.2017.7024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
35 Forrest ME, Khalil AM. Review: Regulation of the cancer epigenome by long non-coding RNAs. Cancer Lett 2017;407:106-12. [PMID: 28400335 DOI: 10.1016/j.canlet.2017.03.040] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 11.4] [Reference Citation Analysis]
36 Ning W, Li H, Meng F, Cheng J, Song X, Zhang G, Wang W, Wu S, Fang J, Ma K, Yang J, Pei D, Dong F. Identification of differential metabolic characteristics between tumor and normal tissue from colorectal cancer patients by gas chromatography-mass spectrometry. Biomed Chromatogr 2017;31. [PMID: 28475217 DOI: 10.1002/bmc.3999] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
37 Ding M, Bu X, Li Z, Xu H, Feng L, Hu J, Wei X, Gao J, Tao Y, Cai B, Liu Y, Qu X, Shen L. NDRG2 ablation reprograms metastatic cancer cells towards glutamine dependence via the induction of ASCT2. Int J Biol Sci 2020;16:3100-15. [PMID: 33162818 DOI: 10.7150/ijbs.48066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Zhang S, Yang Y, Hua Y, Hu C, Zhong Y. NCTD elicits proapoptotic and antiglycolytic effects on colorectal cancer cells via modulation of Fam46c expression and inhibition of ERK1/2 signaling. Mol Med Rep 2020;22:774-82. [PMID: 32468032 DOI: 10.3892/mmr.2020.11151] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
39 Sabnis HS, Somasagara RR, Bunting KD. Targeting MYC Dependence by Metabolic Inhibitors in Cancer. Genes (Basel) 2017;8:E114. [PMID: 28362357 DOI: 10.3390/genes8040114] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
40 Wang H, Su H, Tan Y. UNC5B-AS1 promoted ovarian cancer progression by regulating the H3K27me on NDRG2 via EZH2. Cell Biol Int 2020;44:1028-36. [PMID: 31903696 DOI: 10.1002/cbin.11300] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
41 Neitzel C, Demuth P, Wittmann S, Fahrer J. Targeting Altered Energy Metabolism in Colorectal Cancer: Oncogenic Reprogramming, the Central Role of the TCA Cycle and Therapeutic Opportunities. Cancers (Basel) 2020;12:E1731. [PMID: 32610612 DOI: 10.3390/cancers12071731] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
42 Li J, Li X, Wu L, Pei M, Li H, Jiang Y. miR‐145 inhibits glutamine metabolism through c‐myc/GLS1 pathways in ovarian cancer cells. Cell Biol Int 2019;43:921-30. [DOI: 10.1002/cbin.11182] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
43 Kim G, Lim S, Kim KD. N-myc Downstream-Regulated Gene 2 (NDRG2) Function as a Positive Regulator of Apoptosis: A New Insight into NDRG2 as a Tumor Suppressor. Cells 2021;10:2649. [PMID: 34685629 DOI: 10.3390/cells10102649] [Reference Citation Analysis]
44 Tang T, Wang H, Han Y, Huang H, Niu W, Fei M, Zhu Y. The Role of N-myc Downstream-Regulated Gene Family in Glioma Based on Bioinformatics Analysis. DNA Cell Biol 2021;40:949-68. [PMID: 34115542 DOI: 10.1089/dna.2020.6216] [Reference Citation Analysis]
45 Pan T, Zhang M, Zhang F, Yan G, Ru Y, Wang Q, Zhang Y, Wei X, Xu X, Shen L, Zhang J, Wu K, Yao L, Li X. NDRG2 overexpression suppresses hepatoma cells survival during metabolic stress through disturbing the activation of fatty acid oxidation. Biochemical and Biophysical Research Communications 2017;483:860-6. [DOI: 10.1016/j.bbrc.2017.01.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
46 Wu Q, Zheng K, Liao S, Ding Y, Li Y, Mei W. Arene Ruthenium(II) Complexes as Low-Toxicity Inhibitor against the Proliferation, Migration, and Invasion of MDA-MB-231 Cells through Binding and Stabilizing c-myc G-Quadruplex DNA. Organometallics 2016;35:317-26. [DOI: 10.1021/acs.organomet.5b00820] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
47 Zhang M, Liu X, Wang Q, Ru Y, Xiong X, Wu K, Yao L, Li X. NDRG2 acts as a PERK co-factor to facilitate PERK branch and ERS-induced cell death. FEBS Lett 2017;591:3670-81. [DOI: 10.1002/1873-3468.12861] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
48 Lee GY, Chun YS, Shin HW, Park JW. Potential role of the N-MYC downstream-regulated gene family in reprogramming cancer metabolism under hypoxia. Oncotarget 2016;7:57442-51. [PMID: 27447861 DOI: 10.18632/oncotarget.10684] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]